LY315920 (Varespladib)

Catalog No. A10548

LY315920 (Varespladib)是分泌型磷脂酶A2 (sPLA2)的IIa、V和X亚型的抑制剂。

Product Citations

Yap WH, .et al. Differential effects of sPLA2-GV and GX on cellular proliferation and lipid accumulation in HT29 colon cancer cells, Mol Cell Biochem, 2018, Oct;447(1-2):93-101 PMID: 29374817
Yamato Okita, .et al. Interleukin-22-Induced Antimicrobial Phospholipase A2 Group IIA Mediates Protective Innate Immunity of Nonhematopoietic Cells against Listeria monocytogenes, Infect Immun, 2016, Feb; 84(2): 573-579 PMID: 26644377

Technical details

Catalog Num	A10548
M. Wt	380.4
Formula	C21H20N2O5
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	172732-68-2
Synonyms	LY-315920, S-5920
SMILES	CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N

Biological Activity

LY315920 (Varespladib)是分泌型磷脂酶A2 (sPLA2)的IIa、V和X亚型的抑制剂。

Targets

hnsPLA2
7 nM

Solubility *

In vitro (25°C)	DMSO	73 mg/mL (191.9 mM)
	Water	Insoluble
	Ethanol	Insoluble
In vivo	30% PEG400+0.5% Tween80+5% propylene glycol	28 mg/mL
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	26.29 mL	131.44 mL	262.88 mL
0.5 mM	5.26 mL	26.29 mL	52.58 mL
1 mM	2.63 mL	13.14 mL	26.29 mL
5 mM	0.53 mL	2.63 mL	5.26 mL

*The above data is based on the productmolecular weight 380.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.